Chemistry: analytical and immunological testing – Clotting or clotting factor level tests
Reexamination Certificate
2005-03-15
2005-03-15
Saunders, David (Department: 1644)
Chemistry: analytical and immunological testing
Clotting or clotting factor level tests
C435S013000, C436S086000
Reexamination Certificate
active
06867045
ABSTRACT:
The present invention provides an in vitro method useful for the diagnosis of a thrombotic disorder in a subject, having or at risk of having the disorder. Specifically, the disorder exemplified herein is associated with APC resistant Factor V and Va. The clotting time of a test sample is analyzed in the presence and absence of APC and compared with a standard reference sample in order to diagnose the subject.
REFERENCES:
patent: 5051357 (1991-09-01), Hassouna
patent: 5169786 (1992-12-01), Carroll et al.
patent: 5198534 (1993-03-01), Steinbuch et al.
patent: 5443960 (1995-08-01), Dahlback
patent: 5472852 (1995-12-01), Smirnov et al.
patent: WO9310261 (1993-05-01), None
patent: 9417415 (1994-08-01), None
The Merck Index, Eleventh Edition, Merck & Co., Inc., 1989, pp. 735 & 1583.*
Physicians' Desk Reference, 48th Edition, pp. 894 & 2538, 1994.*
Dahlback et al, Proc. Natl. Acad. Sci., USA, 91, 1396-1400, 1994.*
Griffin, John H. et al, , “Anticoagulant Protein C Pathway Defective in Majority of Thrombophilic Patients,”Blood,vol. 82, No. 7, pp. 1989-1993, 1993.
Blood Coagulation Factor Va Abnormality Associated with Resistance to Activated Protein C in Venous Thrombophilia, Sun et al.,Blood,No. 11, 83:3120-3125, Jun. 1, 1994.
Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Predicition of cofactor . . . , Dahlback, et al.,Proc. Natl. Acad. Sci. USA, 90:10004-1008, 2/93.
Multicenter Evaluation of a Kit for Activated Protein C Resistance on Various Coagulation Instruments Using Plasmas from Health Individuals, Rosen, et al.,Thrombosis and Haemostasis, No. 2, 72:255-260, 1994.
Diagnosis of activated protein C resistance (factor V Leiden), Baker, et al.,The Lancet, 44:162, Oct. 22, 1994.
Modified test for activated protein C resistance, Noel W. Preston,The Lancet, 44:162-163, Oct. 22, 1994.
COATEST—APC Resistance, Chromogenix AB, Sweden.
Greengard et al.,The New England Journal of Medicine,vol. 33, No. 23, Dec. 8, 1994, pp. 1559-1562.
Bertina et al.,Nature,vol. 369, May 5, 1994, pp. 64-67.
Voorberg et al.The Lancet,vol. 343, Jun. 18, 1994, pp. 1535-1536.
Legnani et al.The Lancet,vol.. 343 Feb. 26, 1994, pp. 541-542.
Zoller et al.The Lancetvol. 343, Jun. 18, 1994, pp. 1536-1538.
Griffin John H.
Le Dzung T.
Rapaport Samuel I.
Gray Cary Ware & Freidenrich LLP
Saunders David
The Regents of the University of California
The Scripps Research Institute
LandOfFree
Method for diagnosis of thrombotic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for diagnosis of thrombotic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for diagnosis of thrombotic disorders will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3434392